MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers
Christian Steidl, Sohrab P. Shah, Bruce W. Woolcock, Lixin Rui(National Cancer Institute), Masahiro Kawahara(Albert Einstein College of Medicine), Pedro Farinha, Nathalie A. Johnson, Yongjun Zhao(BC Cancer Agency), Adèle Telenius, Susana Ben Neriah, Andrew McPherson, Barbara Meissner, Ujunwa Cynthia Okoye-Okafor(Albert Einstein College of Medicine), Arjan Diepstra(University Medical Center Groningen), Anke van den Berg(University Medical Center Groningen), Mark Sun, Gillian Leung, Steven J.M. Jones(BC Cancer Agency), Joseph M. Connors(BC Cancer Agency), David G. Huntsman, Kerry J. Savage(BC Cancer Agency), Lisa M. Rimsza(University of Arizona), Douglas E. Horsman, Louis M. Staudt(National Cancer Institute), Ulrich Steidl(Albert Einstein College of Medicine), Marco A. Marra(University of British Columbia), Randy D. Gascoyne
Cited by 611
Abstract
Related Papers
No related papers found
Powered by citation graph analysis